lost weight on semaglutide but not tirzepatide and Loss Program in Houston at Amerejuve MedSpa 10 Reasons You Are NOT

van BergenhenegouwenJBraberSLoonstraRBuurmanNRuttenLKnippingKet al

COA / Lab results Evidence: Clinical trial Pros Triple GLP-1 / GIP / glucagon agonism in one peptide raises energy expenditure, not appetite alone Largest weight reduction reported for an incretin-class compound (~24% at 12 mg, 48-wk phase 2) Reductions in HbA1c, visceral fat and liver-fat content across trials Once-weekly subcutaneous dosing (albumin-bound half-life) Cons GI effects require gradual multi-week dose titration Newest of the GLP-1 class phase 3 (TRIUMPH) topline only

Katsurada K, Maejima Y, Nakata M, Kodaira M, Suyama S, Iwasaki Y, et al

Patent US2477812